Litigation

Recent Posts

High Court Will Consider Whether Reverse-Payment Settlements Are Anti-Competitive
Posted on 8 Dec 2012 by Joan Grossman

WASHINGTON, D.C. — (Mealey's) The Supreme Court on Dec. 7 granted the Federal Trade Commission’s petition for a writ of certiorari seeking consideration of whether reverse-payment settlements of patent litigation between the holder of... Read More

Tags: Supreme Court , Hatch-Waxman , Third Circuit , Second Circuit , Federal Circuit , Federal Trade Commission Act , scope-of-the-patent rule , Antitrust , Patent and Trademark Office , 11th Circuit , patent litigation , In re K-Dur Antitrust Litigation , Litigation , Patents , generic drugs , Federal Trade Commission , Federal Trade Commission v. Watson Pharmaceuticals , Watson Pharmaceuticals Inc. , FTC , patent infringement

High Court: Reverse-Payment Settlements Are Not Immune From Antitrust Scrutiny
Posted on 17 Jun 2013 by Joan Grossman

WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on June 17 ruled 5-3 that reverse-payment settlements of patent litigation between the holder of a drug patent and potential generic manufacturers of the drug are not necessarily immunized from... Read More

Tags: Solvay Pharmaceuticals Inc. Actavis Inc. , reverse-payment settlements , Antitrust , Paddock Holdings Inc. , Par Pharmaceutical Cos. Inc. , patent litigation , 11th Circuit U.S. Court of Appeals , Litigation , Federal Trade Commission v. Actavis , Federal Trade Commission , U.S. Supreme Court , Watson Pharmaceuticals Inc.

3rd Circuit Says Design Defect Claims For Generic Fosamax Are Preempted
Posted on 1 May 2014 by Tom Moylan

PHILADELPHIA — (Mealey’s) Strict liability design defect claims involving generic versions of the osteoporosis drug Fosamax are preempted by federal law despite plaintiffs’ attempts to narrow U.S. Supreme Court case law, a panel of the... Read More

Tags: Third Circuit , preemption , In Re: Fosamax [Alendronate Sodium] Products Liability Litigation [No. II] , Mylan Pharmaceuticals Inc. , Sun Pharmaceutical Industries Inc. , Apotex Corp. , Litigation , osteoporosis drug , multidistrict litigation , Merck Sharp & Dohme Corp. , Fosamax , U.S. Supreme Court , MDL , torts , Watson Pharmaceuticals Inc. , Teva Pharmaceuticals USA , Barr Pharmaceuticals Inc.